Long-Term Cardiac and Cerebrovascular Events after Pancreatectomy for Presumed Benign or Low-Risk Pancreatic Disease: A Population-Based Cohort Study
This population-based cohort study found that pancreatectomy for presumed benign or low-risk pancreatic disease was not significantly associated with an increased long-term risk of cardiac or cerebrovascular events compared to matched controls, although exploratory analyses suggested potential age-specific differences that warrant further investigation.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
The pancreas is a small, unassuming organ tucked deep inside the abdomen, yet it performs two vital jobs that keep the body running smoothly. First, it acts as a chemical factory, releasing enzymes that help digest food. Second, it functions as a hormonal regulator, producing insulin to manage blood sugar levels. Because of these roles, removing part or all of the pancreas is a major life-altering event. While surgeons often remove this organ to save lives from aggressive cancers, modern imaging technology has become so sensitive that it can now spot tiny, subtle abnormalities that might never cause harm. Sometimes, doctors remove these small, likely benign growths just to be safe, a decision driven by the fear of missing a cancer that hasn't fully formed yet. This leaves a difficult question for patients and doctors: if the surgery was performed on a harmless condition, does the operation itself create new, long-term dangers for the heart and brain?
A team of researchers in Japan set out to answer this question by looking at the long-term health of people who had their pancreas removed for reasons other than cancer. They wanted to know if the surgery itself increased the risk of heart attacks or strokes years down the line, once the immediate recovery period was over. To do this, they turned to a massive digital record of health information covering millions of people in Shizuoka Prefecture. They identified 269 adults who underwent pancreatic surgery between 2012 and 2022 without a diagnosis of pancreatic cancer. To ensure a fair comparison, they matched each of these patients with twenty similar people from the general population who had not had the surgery. These matches were based on age, sex, and existing health conditions like diabetes, high blood pressure, and heart disease, creating two groups that were nearly identical at the start.
The researchers then waited. They deliberately ignored the first year after the surgery to avoid counting any complications that happened during the immediate recovery. Starting one year after the operation, they tracked both groups for up to ten years, watching to see who developed heart problems or strokes. The results were reassuring in the big picture. After balancing out the known health risks, the study found no clear evidence that having the pancreas removed made people significantly more likely to suffer a heart attack or a stroke compared to those who did not have the surgery. In the group that had the operation, about 3.7 percent experienced a heart event, while in the comparison group, the number was 4.8 percent. For strokes, the rates were 5.6 percent for the surgery group and 7.3 percent for the others. The statistical analysis showed that the surgery itself did not appear to be the driving force behind these events.
However, the story is not entirely simple. When the researchers looked closer at specific groups of people, they noticed some patterns that might be worth watching, even though the numbers were too small to be certain. They found that people under the age of seventy who had the surgery seemed to have a higher rate of heart and brain events compared to their non-surgery peers of the same age. In contrast, for people over seventy, the rates were similar between the two groups. This suggests that age might play a role in how the body reacts to the loss of pancreatic tissue, but the study was not large enough to confirm this as a rule. The researchers also noted that the study could not track whether the surgery caused new diabetes or worsened existing blood sugar control, factors that are known to affect heart health. Because the data did not include details on how well patients managed their blood sugar after the operation, it remains possible that metabolic changes triggered by the surgery could influence long-term risks in ways the study could not measure.
Ultimately, this research offers a measure of peace of mind for patients facing surgery for uncertain, likely benign pancreatic conditions. It suggests that, on average, the procedure does not carry a hidden, long-term penalty for the heart or brain that outweighs the risks of leaving a suspicious growth untreated. The findings do not rule out the possibility that some individuals, particularly younger patients, might face different risks, but they indicate that the surgery itself is not a direct cause of widespread vascular failure. For doctors and patients, the takeaway is that while the surgery is a major intervention, the long-term outlook for heart and brain health appears stable when compared to the general population, provided that standard health factors like diabetes and blood pressure are managed carefully. The study serves as a reminder that while we can now see tiny abnormalities with great clarity, the decision to operate must still weigh the known benefits against the unknown long-term consequences, a balance that this research helps to clarify without offering a final, absolute verdict.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.